None
Quote | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Last: | $0.451275 |
---|---|
Change Percent: | -0.55% |
Open: | $0.455 |
Close: | $0.451275 |
High: | $0.475 |
Low: | $0.4475 |
Volume: | 1,001,646 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...
Message Board Posts | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Subject | By | Source | When |
---|---|---|---|
Of course Nemesis forgot part of the cost | XMaster2023 | investorshub | 06/01/2024 12:03:00 PM |
Your welcome. Have a great weekend. | RobotDroid | investorshub | 06/01/2024 12:00:12 PM |
Another weekend of a lot of you doing | RobotDroid | investorshub | 06/01/2024 11:58:37 AM |
totally useless your response to such individuals | Karlchen | investorshub | 06/01/2024 9:26:44 AM |
totally useless your response to such individuals | Karlchen | investorshub | 06/01/2024 9:26:43 AM |
News, Short Squeeze, Breakout and More Instantly...
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...